 | • レポートコード：D005-00317 • 出版社/出版日：GlobalInfoResearch / 2020年5月29日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、108ページ • 納品方法：Eメール • 産業分類：医療・製薬 |
| Single User | ￥515,040 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥772,560 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,030,080 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本調査レポートでは、短腸症候群治療薬の世界市場を広く調査・分析し、今後の市場展望をまとめております。短腸症候群治療薬の種類別市場規模（GLP-2、成長ホルモン、グルタミン、その他）、用途別市場規模（病院薬局、小売薬局、オンライン薬局）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、企業別販売量と市場シェア、販売チャネルなどの情報を掲載しています。 ・市場概要 ・企業情報（販売量、市場シェア、製品概要、SWOT分析）：Ardelyx、Sancilio & Company、Merck、Emmaus Life Sciences、OxThera、GLyPharma Therapeutic、Zealand Pharma、Nutrinia、Naia Pharmaceuticals、Takeda ・地域別グローバル市場分析 2015年-2020年 ・短腸症候群治療薬の北米市場（アメリカ、カナダ、メキシコ） ・短腸症候群治療薬のヨーロッパ市場（ドイツ、イギリス、フランス、ロシア、イタリア） ・短腸症候群治療薬のアジア市場（中国、日本、韓国、インド、東南アジア、オーストラリア） ・短腸症候群治療薬の南米市場（ブラジル、アルゼンチン） ・短腸症候群治療薬の中東・アフリカ市場（サウジアラビア、トルコ、エジプト、南アフリカ） ・種類別分析：GLP-2、成長ホルモン、グルタミン、その他 ・用途別分析：病院薬局、小売薬局、オンライン薬局 ・地域別市場規模予測 2021年-2025年 ・販売チャネル、流通業者、代理店 ・調査の結果・結論 |
Market Overview
The global Drugs for Short Bowel Syndrome market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019.
The Drugs for Short Bowel Syndrome market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
Market segmentation
Drugs for Short Bowel Syndrome market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
By Type, Drugs for Short Bowel Syndrome market has been segmented into:
GLP-2
Growth Hormone
Glutamine
Other
By Application, Drugs for Short Bowel Syndrome has been segmented into:
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Drugs for Short Bowel Syndrome market presented in the report. This section sheds light on the sales growth of different regional and country-level Drugs for Short Bowel Syndrome markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Drugs for Short Bowel Syndrome market.
The report offers in-depth assessment of the growth and other aspects of the Drugs for Short Bowel Syndrome market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia and Australia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Competitive Landscape and Drugs for Short Bowel Syndrome Market Share Analysis
Drugs for Short Bowel Syndrome competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Drugs for Short Bowel Syndrome sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Drugs for Short Bowel Syndrome sales, revenue and market share for each player covered in this report.
The major players covered in Drugs for Short Bowel Syndrome are:
Ardelyx
Sancilio & Company
Merck
Emmaus Life Sciences
OxThera
GLyPharma Therapeutic
Zealand Pharma
Nutrinia
Naia Pharmaceuticals
Takeda
Table of Contents
1 Drugs for Short Bowel Syndrome Market Overview
1.1 Product Overview and Scope of Drugs for Short Bowel Syndrome
1.2 Classification of Drugs for Short Bowel Syndrome by Type
1.2.1 Global Drugs for Short Bowel Syndrome Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 Global Drugs for Short Bowel Syndrome Revenue Market Share by Type in 2019
1.2.3 GLP-2
1.2.4 Growth Hormone
1.2.5 Glutamine
1.2.6 Other
1.3 Global Drugs for Short Bowel Syndrome Market by Application
1.3.1 Overview: Global Drugs for Short Bowel Syndrome Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Hospital Pharmacies
1.3.3 Retail Pharmacies
1.3.4 Online Pharmacies
1.4 Global Drugs for Short Bowel Syndrome Market by Regions
1.4.1 Global Drugs for Short Bowel Syndrome Market Size by Regions: 2015 VS 2019 VS 2025
1.4.2 Global Market Size of Drugs for Short Bowel Syndrome (2015-2025)
1.4.3 North America (USA, Canada and Mexico) Drugs for Short Bowel Syndrome Status and Prospect (2015-2025)
1.4.4 Europe (Germany, France, UK, Russia and Italy) Drugs for Short Bowel Syndrome Status and Prospect (2015-2025)
1.4.5 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Drugs for Short Bowel Syndrome Status and Prospect (2015-2025)
1.4.6 South America (Brazil, Argentina, Colombia) Drugs for Short Bowel Syndrome Status and Prospect (2015-2025)
1.4.7 Middle East & Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Drugs for Short Bowel Syndrome Status and Prospect (2015-2025)
2 Company Profiles
2.1 Ardelyx
2.1.1 Ardelyx Details
2.1.2 Ardelyx Major Business and Total Revenue (Financial Highlights) Analysis
2.1.3 Ardelyx SWOT Analysis
2.1.4 Ardelyx Product and Services
2.1.5 Ardelyx Drugs for Short Bowel Syndrome Revenue, Gross Margin and Market Share (2018-2019)
2.2 Sancilio & Company
2.2.1 Sancilio & Company Details
2.2.2 Sancilio & Company Major Business and Total Revenue (Financial Highlights) Analysis
2.2.3 Sancilio & Company SWOT Analysis
2.2.4 Sancilio & Company Product and Services
2.2.5 Sancilio & Company Drugs for Short Bowel Syndrome Revenue, Gross Margin and Market Share (2018-2019)
2.3 Merck
2.3.1 Merck Details
2.3.2 Merck Major Business and Total Revenue (Financial Highlights) Analysis
2.3.3 Merck SWOT Analysis
2.3.4 Merck Product and Services
2.3.5 Merck Drugs for Short Bowel Syndrome Revenue, Gross Margin and Market Share (2018-2019)
2.4 Emmaus Life Sciences
2.4.1 Emmaus Life Sciences Details
2.4.2 Emmaus Life Sciences Major Business and Total Revenue (Financial Highlights) Analysis
2.4.3 Emmaus Life Sciences SWOT Analysis
2.4.4 Emmaus Life Sciences Product and Services
2.4.5 Emmaus Life Sciences Drugs for Short Bowel Syndrome Revenue, Gross Margin and Market Share (2018-2019)
2.5 OxThera
2.5.1 OxThera Details
2.5.2 OxThera Major Business and Total Revenue (Financial Highlights) Analysis
2.5.3 OxThera SWOT Analysis
2.5.4 OxThera Product and Services
2.5.5 OxThera Drugs for Short Bowel Syndrome Revenue, Gross Margin and Market Share (2018-2019)
2.6 GLyPharma Therapeutic
2.6.1 GLyPharma Therapeutic Details
2.6.2 GLyPharma Therapeutic Major Business and Total Revenue (Financial Highlights) Analysis
2.6.3 GLyPharma Therapeutic SWOT Analysis
2.6.4 GLyPharma Therapeutic Product and Services
2.6.5 GLyPharma Therapeutic Drugs for Short Bowel Syndrome Revenue, Gross Margin and Market Share (2018-2019)
2.7 Zealand Pharma
2.7.1 Zealand Pharma Details
2.7.2 Zealand Pharma Major Business and Total Revenue (Financial Highlights) Analysis
2.7.3 Zealand Pharma SWOT Analysis
2.7.4 Zealand Pharma Product and Services
2.7.5 Zealand Pharma Drugs for Short Bowel Syndrome Revenue, Gross Margin and Market Share (2018-2019)
2.8 Nutrinia
2.8.1 Nutrinia Details
2.8.2 Nutrinia Major Business and Total Revenue (Financial Highlights) Analysis
2.8.3 Nutrinia SWOT Analysis
2.8.4 Nutrinia Product and Services
2.8.5 Nutrinia Drugs for Short Bowel Syndrome Revenue, Gross Margin and Market Share (2018-2019)
2.9 Naia Pharmaceuticals
2.9.1 Naia Pharmaceuticals Details
2.9.2 Naia Pharmaceuticals Major Business and Total Revenue (Financial Highlights) Analysis
2.9.3 Naia Pharmaceuticals SWOT Analysis
2.9.4 Naia Pharmaceuticals Product and Services
2.9.5 Naia Pharmaceuticals Drugs for Short Bowel Syndrome Revenue, Gross Margin and Market Share (2018-2019)
2.10 Takeda
2.10.1 Takeda Details
2.10.2 Takeda Major Business and Total Revenue (Financial Highlights) Analysis
2.10.3 Takeda SWOT Analysis
2.10.4 Takeda Product and Services
2.10.5 Takeda Drugs for Short Bowel Syndrome Revenue, Gross Margin and Market Share (2018-2019)
3 Market Competition, by Players
3.1 Global Drugs for Short Bowel Syndrome Revenue and Share by Players (2015-2020)
3.2 Market Concentration Rate
3.2.1 Top 5 Drugs for Short Bowel Syndrome Players Market Share
3.2.2 Top 10 Drugs for Short Bowel Syndrome Players Market Share
3.3 Market Competition Trend
4 Market Size by Regions
4.1 Global Drugs for Short Bowel Syndrome Revenue and Market Share by Regions
4.2 North America Drugs for Short Bowel Syndrome Revenue and Growth Rate (2015-2020)
4.3 Europe Drugs for Short Bowel Syndrome Revenue and Growth Rate (2015-2020)
4.4 Asia-Pacific Drugs for Short Bowel Syndrome Revenue and Growth Rate (2015-2020)
4.5 South America Drugs for Short Bowel Syndrome Revenue and Growth Rate (2015-2020)
4.6 Middle East & Africa Drugs for Short Bowel Syndrome Revenue and Growth Rate (2015-2020)
5 North America Drugs for Short Bowel Syndrome Revenue by Countries
5.1 North America Drugs for Short Bowel Syndrome Revenue by Countries (2015-2020)
5.2 USA Drugs for Short Bowel Syndrome Revenue and Growth Rate (2015-2020)
5.3 Canada Drugs for Short Bowel Syndrome Revenue and Growth Rate (2015-2020)
5.4 Mexico Drugs for Short Bowel Syndrome Revenue and Growth Rate (2015-2020)
6 Europe Drugs for Short Bowel Syndrome Revenue by Countries
6.1 Europe Drugs for Short Bowel Syndrome Revenue by Countries (2015-2020)
6.2 Germany Drugs for Short Bowel Syndrome Revenue and Growth Rate (2015-2020)
6.3 UK Drugs for Short Bowel Syndrome Revenue and Growth Rate (2015-2020)
6.4 France Drugs for Short Bowel Syndrome Revenue and Growth Rate (2015-2020)
6.5 Russia Drugs for Short Bowel Syndrome Revenue and Growth Rate (2015-2020)
6.6 Italy Drugs for Short Bowel Syndrome Revenue and Growth Rate (2015-2020)
7 Asia-Pacific Drugs for Short Bowel Syndrome Revenue by Countries
7.1 Asia-Pacific Drugs for Short Bowel Syndrome Revenue by Countries (2015-2020)
7.2 China Drugs for Short Bowel Syndrome Revenue and Growth Rate (2015-2020)
7.3 Japan Drugs for Short Bowel Syndrome Revenue and Growth Rate (2015-2020)
7.4 Korea Drugs for Short Bowel Syndrome Revenue and Growth Rate (2015-2020)
7.5 India Drugs for Short Bowel Syndrome Revenue and Growth Rate (2015-2020)
7.6 Southeast Asia Drugs for Short Bowel Syndrome Revenue and Growth Rate (2015-2020)
8 South America Drugs for Short Bowel Syndrome Revenue by Countries
8.1 South America Drugs for Short Bowel Syndrome Revenue by Countries (2015-2020)
8.2 Brazil Drugs for Short Bowel Syndrome Revenue and Growth Rate (2015-2020)
8.3 Argentina Drugs for Short Bowel Syndrome Revenue and Growth Rate (2015-2020)
9 Middle East & Africa Revenue Drugs for Short Bowel Syndrome by Countries
9.1 Middle East & Africa Drugs for Short Bowel Syndrome Revenue by Countries (2015-2020)
9.2 Saudi Arabia Drugs for Short Bowel Syndrome Revenue and Growth Rate (2015-2020)
9.3 UAE Drugs for Short Bowel Syndrome Revenue and Growth Rate (2015-2020)
9.4 Egypt Drugs for Short Bowel Syndrome Revenue and Growth Rate (2015-2020)
9.5 South Africa Drugs for Short Bowel Syndrome Revenue and Growth Rate (2015-2020)
10 Market Size Segment by Type
10.1 Global Drugs for Short Bowel Syndrome Revenue and Market Share by Type (2015-2020)
10.2 Global Drugs for Short Bowel Syndrome Market Forecast by Type (2019-2024)
10.3 GLP-2 Revenue Growth Rate (2015-2025)
10.4 Growth Hormone Revenue Growth Rate (2015-2025)
10.5 Glutamine Revenue Growth Rate (2015-2025)
10.6 Other Revenue Growth Rate (2015-2025)
11 Global Drugs for Short Bowel Syndrome Market Segment by Application
11.1 Global Drugs for Short Bowel Syndrome Revenue Market Share by Application (2015-2020)
11.2 Drugs for Short Bowel Syndrome Market Forecast by Application (2019-2024)
11.3 Hospital Pharmacies Revenue Growth (2015-2020)
11.4 Retail Pharmacies Revenue Growth (2015-2020)
11.5 Online Pharmacies Revenue Growth (2015-2020)
12 Global Drugs for Short Bowel Syndrome Market Size Forecast (2021-2025)
12.1 Global Drugs for Short Bowel Syndrome Market Size Forecast (2021-2025)
12.2 Global Drugs for Short Bowel Syndrome Market Forecast by Regions (2021-2025)
12.3 North America Drugs for Short Bowel Syndrome Revenue Market Forecast (2021-2025)
12.4 Europe Drugs for Short Bowel Syndrome Revenue Market Forecast (2021-2025)
12.5 Asia-Pacific Drugs for Short Bowel Syndrome Revenue Market Forecast (2021-2025)
12.6 South America Drugs for Short Bowel Syndrome Revenue Market Forecast (2021-2025)
12.7 Middle East & Africa Drugs for Short Bowel Syndrome Revenue Market Forecast (2021-2025)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source
14.3 Disclaimer
14.4 About US
Table 1. Global Drugs for Short Bowel Syndrome Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of Drugs for Short Bowel Syndrome by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global Drugs for Short Bowel Syndrome Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 4. Global Market Drugs for Short Bowel Syndrome Revenue (Million USD) Comparison by Regions 2015-2025
Table 5. Ardelyx Corporate Information, Location and Competitors
Table 6. Ardelyx Drugs for Short Bowel Syndrome Major Business
Table 7. Ardelyx Drugs for Short Bowel Syndrome Total Revenue (USD Million) (2017-2018)
Table 8. Ardelyx SWOT Analysis
Table 9. Ardelyx Drugs for Short Bowel Syndrome Product and Solutions
Table 10. Ardelyx Drugs for Short Bowel Syndrome Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 11. Sancilio & Company Corporate Information, Location and Competitors
Table 12. Sancilio & Company Drugs for Short Bowel Syndrome Major Business
Table 13. Sancilio & Company Drugs for Short Bowel Syndrome Total Revenue (USD Million) (2018-2019)
Table 14. Sancilio & Company SWOT Analysis
Table 15. Sancilio & Company Drugs for Short Bowel Syndrome Product and Solutions
Table 16. Sancilio & Company Drugs for Short Bowel Syndrome Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 17. Merck Corporate Information, Location and Competitors
Table 18. Merck Drugs for Short Bowel Syndrome Major Business
Table 19. Merck Drugs for Short Bowel Syndrome Total Revenue (USD Million) (2017-2018)
Table 20. Merck SWOT Analysis
Table 21. Merck Drugs for Short Bowel Syndrome Product and Solutions
Table 22. Merck Drugs for Short Bowel Syndrome Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 23. Emmaus Life Sciences Corporate Information, Location and Competitors
Table 24. Emmaus Life Sciences Drugs for Short Bowel Syndrome Major Business
Table 25. Emmaus Life Sciences Drugs for Short Bowel Syndrome Total Revenue (USD Million) (2017-2018)
Table 26. Emmaus Life Sciences SWOT Analysis
Table 27. Emmaus Life Sciences Drugs for Short Bowel Syndrome Product and Solutions
Table 28. Emmaus Life Sciences Drugs for Short Bowel Syndrome Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 29. OxThera Corporate Information, Location and Competitors
Table 30. OxThera Drugs for Short Bowel Syndrome Major Business
Table 31. OxThera Drugs for Short Bowel Syndrome Total Revenue (USD Million) (2017-2018)
Table 32. OxThera SWOT Analysis
Table 33. OxThera Drugs for Short Bowel Syndrome Product and Solutions
Table 34. OxThera Drugs for Short Bowel Syndrome Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 35. GLyPharma Therapeutic Corporate Information, Location and Competitors
Table 36. GLyPharma Therapeutic Drugs for Short Bowel Syndrome Major Business
Table 37. GLyPharma Therapeutic Drugs for Short Bowel Syndrome Total Revenue (USD Million) (2017-2018)
Table 38. GLyPharma Therapeutic SWOT Analysis
Table 39. GLyPharma Therapeutic Drugs for Short Bowel Syndrome Product and Solutions
Table 40. GLyPharma Therapeutic Drugs for Short Bowel Syndrome Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 41. Zealand Pharma Corporate Information, Location and Competitors
Table 42. Zealand Pharma Drugs for Short Bowel Syndrome Major Business
Table 43. Zealand Pharma Drugs for Short Bowel Syndrome Total Revenue (USD Million) (2017-2018)
Table 44. Zealand Pharma SWOT Analysis
Table 45. Zealand Pharma Drugs for Short Bowel Syndrome Product and Solutions
Table 46. Zealand Pharma Drugs for Short Bowel Syndrome Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 47. Nutrinia Corporate Information, Location and Competitors
Table 48. Nutrinia Drugs for Short Bowel Syndrome Major Business
Table 49. Nutrinia Drugs for Short Bowel Syndrome Total Revenue (USD Million) (2017-2018)
Table 50. Nutrinia SWOT Analysis
Table 51. Nutrinia Drugs for Short Bowel Syndrome Product and Solutions
Table 52. Nutrinia Drugs for Short Bowel Syndrome Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 53. Naia Pharmaceuticals Corporate Information, Location and Competitors
Table 54. Naia Pharmaceuticals Drugs for Short Bowel Syndrome Major Business
Table 55. Naia Pharmaceuticals Drugs for Short Bowel Syndrome Total Revenue (USD Million) (2017-2018)
Table 56. Naia Pharmaceuticals SWOT Analysis
Table 57. Naia Pharmaceuticals Drugs for Short Bowel Syndrome Product and Solutions
Table 58. Naia Pharmaceuticals Drugs for Short Bowel Syndrome Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 59. Takeda Corporate Information, Location and Competitors
Table 60. Takeda Drugs for Short Bowel Syndrome Major Business
Table 61. Takeda Drugs for Short Bowel Syndrome Total Revenue (USD Million) (2017-2018)
Table 62. Takeda SWOT Analysis
Table 63. Takeda Drugs for Short Bowel Syndrome Product and Solutions
Table 64. Takeda Drugs for Short Bowel Syndrome Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 65. Global Drugs for Short Bowel Syndrome Revenue (Million USD) by Players (2015-2020)
Table 66. Global Drugs for Short Bowel Syndrome Revenue Share by Players (2015-2020)
Table 67. Global Drugs for Short Bowel Syndrome Revenue (Million USD) by Regions (2015-2020)
Table 68. Global Drugs for Short Bowel Syndrome Revenue Market Share by Regions (2015-2020)
Table 69. North America Drugs for Short Bowel Syndrome Revenue by Countries (2015-2020)
Table 70. North America Drugs for Short Bowel Syndrome Revenue Market Share by Countries (2015-2020)
Table 71. Europe Drugs for Short Bowel Syndrome Revenue (Million USD) by Countries (2015-2020)
Table 72. Asia-Pacific Drugs for Short Bowel Syndrome Revenue (Million USD) by Countries (2015-2020)
Table 73. South America Drugs for Short Bowel Syndrome Revenue by Countries (2015-2020)
Table 74. South America Drugs for Short Bowel Syndrome Revenue Market Share by Countries (2015-2020)
Table 75. Middle East and Africa Drugs for Short Bowel Syndrome Revenue (Million USD) by Countries (2015-2020)
Table 76. Middle East and Africa Drugs for Short Bowel Syndrome Revenue Market Share by Countries (2015-2020)
Table 77. Global Drugs for Short Bowel Syndrome Revenue (Million USD) by Type (2015-2020)
Table 78. Global Drugs for Short Bowel Syndrome Revenue Share by Type (2015-2020)
Table 79. Global Drugs for Short Bowel Syndrome Revenue Forecast by Type (2021-2025)
Table 80. Global Drugs for Short Bowel Syndrome Revenue by Application (2015-2020)
Table 81. Global Drugs for Short Bowel Syndrome Revenue Share by Application (2015-2020)
Table 82. Global Drugs for Short Bowel Syndrome Revenue Forecast by Application (2021-2025)
Table 83. Global Drugs for Short Bowel Syndrome Revenue (Million USD) Forecast by Regions (2021-2025)
List of Figures
Figure 1. Drugs for Short Bowel Syndrome Picture
Figure 2. Global Drugs for Short Bowel Syndrome Revenue Market Share by Type in 2019
Figure 3. GLP-2 Picture
Figure 4. Growth Hormone Picture
Figure 5. Glutamine Picture
Figure 6. Other Picture
Figure 7. Drugs for Short Bowel Syndrome Revenue Market Share by Application in 2019
Figure 8. Hospital Pharmacies Picture
Figure 9. Retail Pharmacies Picture
Figure 10. Online Pharmacies Picture
Figure 11. Global Drugs for Short Bowel Syndrome Revenue (USD Million) and Growth Rate (2015-2025)
Figure 12. North America Drugs for Short Bowel Syndrome Revenue (Million USD) and Growth Rate (2015-2025)
Figure 13. Europe Drugs for Short Bowel Syndrome Revenue (Million USD) and Growth Rate (2015-2025)
Figure 14. Asia-Pacific Drugs for Short Bowel Syndrome Revenue (Million USD) and Growth Rate (2015-2025)
Figure 15. South America Drugs for Short Bowel Syndrome Revenue (Million USD) and Growth Rate (2015-2025)
Figure 16. Middle East and Africa Drugs for Short Bowel Syndrome Revenue (Million USD) and Growth Rate (2015-2025)
Figure 17. Global Drugs for Short Bowel Syndrome Revenue (Million USD) and Growth Rate (2015-2025)
Figure 18. Global Drugs for Short Bowel Syndrome Revenue Share by Players in 2019
Figure 19. Global Top 5 Players Drugs for Short Bowel Syndrome Revenue Market Share in 2019
Figure 20. Global Top 10 Players Drugs for Short Bowel Syndrome Revenue Market Share in 2019
Figure 21. Key Players Market Share Trend
Figure 22. Global Drugs for Short Bowel Syndrome Revenue (Million USD) and Growth Rate (%) (2015-2020)
Figure 23. Global Drugs for Short Bowel Syndrome Revenue Market Share by Regions (2015-2020)
Figure 24. Global Drugs for Short Bowel Syndrome Revenue Market Share by Regions in 2018
Figure 25. North America Drugs for Short Bowel Syndrome Revenue and Growth Rate (2015-2020)
Figure 26. Europe Drugs for Short Bowel Syndrome Revenue and Growth Rate (2015-2020)
Figure 27. Asia-Pacific Drugs for Short Bowel Syndrome Revenue and Growth Rate (2015-2020)
Figure 28. South America Drugs for Short Bowel Syndrome Revenue and Growth Rate (2015-2020)
Figure 29. Middle East and Africa Drugs for Short Bowel Syndrome Revenue and Growth Rate (2015-2020)
Figure 30. North America Drugs for Short Bowel Syndrome Revenue Market Share by Countries (2015-2020)
Figure 31. North America Drugs for Short Bowel Syndrome Revenue Market Share by Countries in 2019
Figure 32. USA Drugs for Short Bowel Syndrome Revenue and Growth Rate (2015-2020)
Figure 33. Canada Drugs for Short Bowel Syndrome Revenue and Growth Rate (2015-2020)
Figure 34. Mexico Drugs for Short Bowel Syndrome Revenue and Growth Rate (2015-2020)
Figure 35. Europe Drugs for Short Bowel Syndrome Revenue Market Share by Countries (2015-2020)
Figure 36. Europe Drugs for Short Bowel Syndrome Revenue Market Share by Countries in 2019
Figure 37. Germany Drugs for Short Bowel Syndrome Revenue and Growth Rate (2015-2020)
Figure 38. UK Drugs for Short Bowel Syndrome Revenue and Growth Rate (2015-2020)
Figure 39. France Drugs for Short Bowel Syndrome Revenue and Growth Rate (2015-2020)
Figure 40. Russia Drugs for Short Bowel Syndrome Revenue and Growth Rate (2015-2020)
Figure 41. Italy Drugs for Short Bowel Syndrome Revenue and Growth Rate (2015-2020)
Figure 42. Asia-Pacific Drugs for Short Bowel Syndrome Revenue Market Share by Countries (2015-2020)
Figure 43. Asia-Pacific Drugs for Short Bowel Syndrome Revenue Market Share by Countries in 2019
Figure 44. China Drugs for Short Bowel Syndrome Revenue and Growth Rate (2015-2020)
Figure 45. Japan Drugs for Short Bowel Syndrome Revenue and Growth Rate (2015-2020)
Figure 46. Korea Drugs for Short Bowel Syndrome Revenue and Growth Rate (2015-2020)
Figure 47. India Drugs for Short Bowel Syndrome Revenue and Growth Rate (2015-2020)
Figure 48. Southeast Asia Drugs for Short Bowel Syndrome Revenue and Growth Rate (2015-2020)
Figure 49. South America Drugs for Short Bowel Syndrome Revenue Market Share by Countries (2015-2020)
Figure 50. South America Drugs for Short Bowel Syndrome Revenue Market Share by Countries in 2019
Figure 51. Brazil Drugs for Short Bowel Syndrome Revenue and Growth Rate (2015-2020)
Figure 52. Argentina Drugs for Short Bowel Syndrome Revenue and Growth Rate (2015-2020)
Figure 53. Middle East and Africa Drugs for Short Bowel Syndrome Revenue Market Share by Countries (2015-2020)
Figure 54. Middle East and Africa Drugs for Short Bowel Syndrome Revenue Market Share by Countries in 2019
Figure 55. Saudi Arabia Drugs for Short Bowel Syndrome Revenue and Growth Rate (2015-2020)
Figure 56. UAE Drugs for Short Bowel Syndrome Revenue and Growth Rate (2015-2020)
Figure 57. Egypt Drugs for Short Bowel Syndrome Revenue and Growth Rate (2015-2020)
Figure 58. South Africa Drugs for Short Bowel Syndrome Revenue and Growth Rate (2015-2020)
Figure 59. Global Drugs for Short Bowel Syndrome Revenue Share by Type (2015-2020)
Figure 60. Global Drugs for Short Bowel Syndrome Revenue Share by Type in 2019
Figure 61. Global Drugs for Short Bowel Syndrome Market Share Forecast by Type (2021-2025)
Figure 62. Global GLP-2 Revenue Growth Rate (2015-2020)
Figure 63. Global Growth Hormone Revenue Growth Rate (2015-2020)
Figure 64. Global Glutamine Revenue Growth Rate (2015-2020)
Figure 65. Global Other Revenue Growth Rate (2015-2020)
Figure 66. Global Drugs for Short Bowel Syndrome Revenue Share by Application (2015-2020)
Figure 67. Global Drugs for Short Bowel Syndrome Revenue Share by Application in 2019
Figure 68. Global Drugs for Short Bowel Syndrome Market Share Forecast by Application (2021-2025)
Figure 69. Global Hospital Pharmacies Revenue Growth Rate (2015-2020)
Figure 70. Global Retail Pharmacies Revenue Growth Rate (2015-2020)
Figure 71. Global Online Pharmacies Revenue Growth Rate (2015-2020)
Figure 72. Global Drugs for Short Bowel Syndrome Revenue (Million USD) and Growth Rate Forecast (2021-2025)
Figure 73. Global Drugs for Short Bowel Syndrome Revenue (Million USD) Forecast by Regions (2021-2025)
Figure 74. Global Drugs for Short Bowel Syndrome Revenue Market Share Forecast by Regions (2021-2025)
Figure 75. North America Drugs for Short Bowel Syndrome Revenue Market Forecast (2021-2025)
Figure 76. Europe Drugs for Short Bowel Syndrome Revenue Market Forecast (2021-2025)
Figure 77. Asia-Pacific Drugs for Short Bowel Syndrome Revenue Market Forecast (2021-2025)
Figure 78. South America Drugs for Short Bowel Syndrome Revenue Market Forecast (2021-2025)
Figure 79. Middle East and Africa Drugs for Short Bowel Syndrome Revenue Market Forecast (2021-2025)
Figure 80. Sales Channel: Direct Channel vs Indirect Channel
下痢を伴う過敏性腸症候群（IBS-D）薬の世界市場 2020年：メーカー別、地域別、種類・用途別 Market Overview The global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 20…- 便秘薬による過敏性腸症候群の世界市場 2020年：メーカー別、地域別、種類・用途別 Market Overview The global Irritable Bowel Syndrome with Constipation Drugs market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. …
- 骨髄異形成症候群（MDS）薬の世界市場 2020年：企業別、地域別、種類・用途別 Market Overview The global Myelodysplastic Syndrome (MDS) Drugs market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of 5.5% in the forecast period of 2020 to 2025 and will expected to reach USD 1798.3 million by 2025, from USD 1452.7 million in 2019. The…
- 炎症性腸疾患治療薬の世界市場 2020年：メーカー別、地域別、種類・用途別 Market Overview The global Inflammatory Bowel Disease Drugs market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Inflammatory…
- バーター症候群薬の世界市場 2020年：企業別、地域別、種類・用途別 Market Overview The global Bartter Syndrome Drugs market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Bartter Syndrome Drugs…